Asthma education: Creating a partnership

Heart and Lung: Journal of Acute and Critical Care

Volumn 29, Issue 3, 2000, Pages 225-236

  Reinke, Lynn F ^a,b   Hoffman, Leslie ^b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; IRRITANT AGENT; LEUKOTRIENE; METHYLPREDNISOLONE; MONTELUKAST; NEDOCROMIL; PIRBUTEROL; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TOBACCO SMOKE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ZILEUTON;

ALLERGY; ASTHMA; CONSULTATION; CORTICOSTEROID THERAPY; COUGHING; DISEASE EXACERBATION; DRUG CHOICE; DYSPNEA; EDUCATION PROGRAM; EMOTION; EXERCISE; FLOWMETER; METERED DOSE INHALER; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SELF MEDICATION; WHEEZING;

EID: 0034122085     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhl.2000.107298     Document Type: Article

References (28)

1. 1. Adams, PF and Marano, MA. Current estimates from the National Health Interview Survey, 1994 Vital Health Statistics 10, 1994
2. 2 Weiss, KB. Seasonal trends in US asthma hospitalizations and mortality. Journal of American Medical Association, 263: 2323-28, May 2, 1990.
3. 3 Smith, DH et al. A national estimate of the economic costs of asthma. American Journal of Respiratory & Critical Care Medicine, 156 (3 Part 1): 787-93, Sept. 1997.
4. 4. Weiss, KB et al. An economic evaluation of asthma in the United States. New England Journal of Medicine, 326: 862, Mar. 26, 1992.
5. 5. Bengt, L & Lahdensuo, A. Is asthma management cost-effective? Patient Education and Counseling, 32: S97-S104, 1997.
6. 6. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health Publication No. 97-4051, Bethesda, MD, April 1997.
7. 7. Management of asthma by patients and families. American Journal of Respiratory & Critical Care Medicine, 149: 554-66, 1994.
8. 8. Drazen, JM Bronchial asthma. In Textbook of Pulmonary Diseases. 6th ed., Vol. II, ed. by GL Baum, JD Crapo, BR Celli, JB Karlinsky. Philadelphia, Lippincott-Raven, pp. 791-805, 1997.
9. 9. Barnes, PJ. Pathophysiology of asthma In Asthma Basic Mechanisms and Clinical Management. 3rd ed., ed. by PJ Barnes, IW Rodger, NC Thomson. San Diego, Academic Press, pp. 487-506, 1998.
10. 10. McFadden, ER. When to use high-dose inhaled steroids Journal of Respiratory Diseases, 12(11): 1005-12, 1991
11. 11. Waldman-Wagner, C. Asthma Care and Patient Education. The Nurse's Role Allen & Hanburys, Research Triangle Park, NC, 1990.
12. 12. Lewis, SM, Collier, IC, and Heitkemper, MM. Medical Surgical Nursing: Assessment and Management of Clinical Problems. 4th ed St Louis, Mosby-Year Book, 1996.
13. 13. American Thoracic Society. Standardization of spirometry -1994 update American Review of Respiratory Diseases, 130: 1285-98, Nov. 1987.
14. 14. Quackenboss, JJ et al. The normal range of diurnal changes in peak expiratory flow rates: relationship to symptoms and respiratory disease. American Journal of Respiratory and Critical Care Medicine, 152: 1107-36, 1995.
15. 15. Longacre, MF & Scanlon, PD. Exercise-induced asthma RT: The Journal for Respiratory Care Practitioners, 5(3): 31-43, April/May 1992.
16. 16. Godrey, S & Bar-Yishay, E. Exercise-induced asthma revisited. Respiratory Medicine, 87.331-44, 1993.
17. 17. Paul, GH & Fafoglis, BA. Exercise, sports and asthma School Nurse, 10:39-40, 42, Oct 1989.
18. 18. Janson-Bjerklie, S et al. Clinical markers of asthma severity and risk. Importance of subjective as well as objective factors. Heart Lung, 21: 265-72, May 1992.
19. 19. Tiep, BI et al. Pursed lips breathing and training using ear oximetry Chest, 90. 218-21, Aug 1986.
20. 20 Freedberg, PD et al Effect of progressive muscle relaxation on the objective symptoms and subjective responses associated with asthma. Heart Lung, 16: 24-30, Jan. 1987
21. 21 Schatz, M et al. The safety of inhaled beta-agonist bronchodilators during pregnancy. Journal of Allergy and Clinical Immunology, 82: 686-95, Oct. 1988.
22. 22. Creer, TL & Levstek, D. Medication compliance and asthma: Overlooking the trees because of the forest. Journal of Asthma, 33(4): 203-11, 1996.
23. 23. US Department of Health and Human Services. Facts About Asthma. National Institutes of Health Publication No. 90-2339, Washington, DC, US Government Printing Office, 1990.
24. 24. Barnes, PJ. Theophylline. In Asthma Basic Mechanisms and Clinical Management. 3rd ed., ed. by PJ Barnes, IW Rodger, NC Thomson. San Diego, Academic Press, pp. 689-706, 1998.
25. 25. Tashkin, DP et al. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study American Journal of Medicine, 81: 81-89, Nov. 14, 1986.
26. 26. Spitzer, WO et al. The use of beta agonists and the risk of death and near death from asthma. New England Journal of Medicine, 326: 501-06, Feb. 20, 1992.
27. 27 Rokosky, JM MDls: Helping patients get it right. Home Healthcare Nurse, 15(1): 13-24, 1997.
28. 28. NHLBI Report of the Work Group on Asthma and Pregnancy Executive summary: Management of asthma during pregnancy. NIH publication 93-3289-A, March 1993, pg. 6.